News

Investment

Occuity lands £343k grant to develop optical diabetes screening device

RxCelerate acquires Methuselah Health – launches “world-beating” proteomics service

Cajal Neuroscience launches with $96 million to transform neurodegeneration drug discovery

Financing led by Column Group and Lux Capital will aim to to accelerate drug discovery by enabling target discovery at unprecedented scale.

Juvena Therapeutics bags $41 million to accelerate biologics for age-related diseases

The lifespan revolution is upon us – get involved and get ahead

Insilico Medicine signs $1.2 billion strategic research collaboration with Sanofi

Marc P Bernegger – making longevity tangible for everybody as soon as possible

SENS Research Foundation announces new fundraising campaign

Neurotrack raises $10m and launches 3-minute digital cognitive screening test

Brian Kennedy – validating aging interventions and why rapamycin is the gold standard

Charles Brenner: longevity is not a simple engineering problem

Aubrey de Grey on longevity at scale

Kizoo invests in rejuvenation startup Mogling Bio

Jim Mellon: Longevity could be the best investment you ever make

Advanced aesthetics report gets under the skin of longevity

‘If you can preserve muscle strength, you will age healthier’

Longevity Science Foundation expands to US with new CEO

ChromaDex and Nestlé announce new Niagen commercial supply agreement and $5m investment

ChromaDex shares promising findings from nicotinamide riboside clinical trial

‘We want to bring the concept of longevity to life’

Smart drug delivery system to treat multiple Alzheimer’s pathologies bags $2.4m funding

Halberd enters strategic alliance for longevity and Alzheimer’s disease

Phase 3 trial shows Alzheimer’s drug slows progression of disease

Certific and PocDoc collaborate to tackle cardiovascular disease

Eye-level longevity – why breakthrough research is top investment opportunity

New $100 million longevity fund puts the spotlight on software

We might not know the future… but we can spot its longevity trends and drivers

FOXO Technologies lists on NYSE American following successful SPAC

Taking the longevity field one step beyond

Rejuvenation Startup Summit 2022 announces programme and speakers

Saudi Government and Insilico Medicine partner to expand region’s biotech capabilities

“At the cutting edge of longevity research”

Find us here ...

© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.